Jill Stefanelli - 16 Nov 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
Gioia Gentile on behalf of Jill Stefanelli by power of attorney
Issuer symbol
N/A
Transactions as of
16 Nov 2023
Net transactions value
$0
Form type
4
Filing time
20 Nov 2023, 18:10:13 UTC
Previous filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +275,000 +110% $0.000000 525,000 16 Nov 2023 Direct F1
transaction NAVB Common Stock Award $0 +416,667 +79% $0.000000 941,667 16 Nov 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares vest upon the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.
F2 Shares vest in three equal tranches, with the first tranche vesting on June 1, 2024 (the "Initial Vesting Date"), with the remaining tranches vesting ratably annually from the Initial Vesting Date over the following two years, subject to the Reporting Person's continuous service to the Company.